POZN

Pozen, Inc. News Headlines

$8.75
*  
0.17
1.91%
Get POZN Alerts
*Delayed - data as of Jul. 10, 2014  -  Find a broker to begin trading POZN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week
7/8/2014 2:11:00 AM - Zacks.com

Pozen Resubmits PA NDA, PDUFA In Two Months?
7/3/2014 9:47:00 AM - Seeking Alpha

Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
6/24/2014 9:18:00 AM - Zacks.com

Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
6/20/2014 9:18:00 AM - Zacks.com

AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape
6/17/2014 9:18:00 AM - Zacks.com

Alcobra Ltd. (ADHD) Jumps: Stock Rises 8.7% - Tale of the Tape
6/12/2014 9:18:00 AM - Zacks.com

BioCryst Pharmaceuticals (BCRX) Soars: Stock Adds 10.9% in Session - Tale of the Tape
5/28/2014 9:18:00 AM - Zacks.com

Orexigen Will Run: Here's Why
5/27/2014 3:47:00 PM - Seeking Alpha

Weekly Insider Sells Highlight: AR, CSCO, SUTR, POZN, JAH
5/27/2014 1:04:50 PM - GuruFocus

Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher - Tale of the Tape
5/15/2014 9:18:00 AM - Zacks.com

Pernix Therapeutics to Acquire U.S. Rights to Glaxo Migraine Drug
5/14/2014 10:23:00 AM - Dow Jones Business News

PERNIX To Buy TREXIMET® Tablets For Migraine From GSK - Quick Facts
5/14/2014 7:48:00 AM - RTT News

Pozen, Inc.: Buy This Biotech For Growth And Income
5/10/2014 9:13:00 AM - Seeking Alpha

Pozen Is Overvalued, More So Now After Recent FDA Rejection - Here Is Why
4/28/2014 11:57:00 AM - Seeking Alpha

Pre-Market Most Active for Apr 28, 2014 : AZN, BAC, PFE, HSBC, FB, NEM, UN, ERIC, FURX, POZN, BLDP, QQQ
4/28/2014 8:38:53 AM - NASDAQ.com News

Pozen's PA8140/PA32540 Receives Complete Response Letter From FDA
4/25/2014 8:45:00 PM - RTT News

Sector Update: Healthcare Stocks Higher Pre-Market; Pozen Rises on Q4 Results
3/5/2014 9:31:56 AM - MT Newswires

Sector Update: Healthcare
3/5/2014 9:31:36 AM - MT Newswires

Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha

Notes From One-On-One Meetings During San Fran Biotech Week - Day 2
1/23/2014 9:05:00 AM - Seeking Alpha

Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha

Pozen, Inc. (POZN) Ex-Dividend Date Scheduled for December 31, 2013
12/30/2013 10:00:02 AM - NASDAQ.com News

Sector Update: Healthcare Stocks Mixed Pre-Market; TSRO Sinks 7% on Phase 3 Results of Rolapitant
12/23/2013 9:19:09 AM - MT Newswires

Sector Update: Healthcare
12/23/2013 9:15:36 AM - MT Newswires

The Market Is Missing Pozen's Potential Cash Distribution And Upcoming Approval
11/7/2013 9:17:45 AM - SeekingAlpha